Invion Ltd has released a press release.
Appendix 4C and Quarterly Activities Report - December 2025
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Invion
- Major Shareholders Lead Invion $1.3M Capital Raise
- Trading Halt
- Pause in Trading
- Hanlim & Korean Government Fund Pathway to Clinical Trial
- Invion Secures Expanded Photosoft Global Exclusive License
Later from Invion
- Appendix 4D and Half Year Financial Report
- Skin Cancer Trial Moves to BCC With More Encouraging Signals
- Appendix 4C and Quarterly Activities Report - March 2026
- Photosoft Platform Expands to Eye Diseases Via Partnership
- Appendix 4C and Quarterly Activities Report - June 2026
Follow Invion into a list and get an email when it puts out news.
Follow Invion